688131 皓元医药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额77,100(63,606)(240,233)57,835116,789
投资活动产生之现金流量净额(176,664)(328,511)(713,002)(305,839)(74,161)
筹资活动产生之现金流量净额47,022409,209360,3241,007,29450,277
汇率变动对现金及现金等价物的影响5,8933,11114,415(7,242)(9,290)
现金及现金等价物净增加/(减少)(46,649)20,202(578,496)752,04783,616
期初现金及现金等价物余额475,466455,2641,033,760281,713198,097
期末现金及现金等价物余额428,817475,466455,2641,033,760281,713